Antibiotic added to chemo in fight against breast cancer recurrence
NCT ID NCT05114720
Summary
This study tested whether adding a common antibiotic called moxifloxacin to standard chemotherapy could help prevent breast cancer from coming back after surgery. Over 550 patients who had surgery for breast cancer were randomly assigned to receive either the antibiotic or a placebo along with their usual chemo drugs. The main goal was to see if the antibiotic group stayed cancer-free for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.